2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prevention and control of animal diseases worldwide<br />
Part I: Economic analysis: prevention versus outbreak costs<br />
5.1.1.2. Key AH problem areas<br />
Argentina was selected as a representative case study in the Americas because of the FMD relevance. Due<br />
to the fact that FMD, <strong>part</strong>icularly in South America, has proven to be a challenge not facing any one<br />
country alone, a regional approach is very important for addressing this animal health problem. Such an<br />
approach is increasingly being taken by the various countries in the region as will be discussed in the<br />
following sections. Therefore, Argentina is being presented here not only on its own merit but also in the<br />
context of its role in the South American region.<br />
FMD is a recurrent disease in South America and appears to be endemic in Bolivia, Ecuador and<br />
Venezuela. The disease occurs sporadically in Argentina, Paraguay, Uruguay, Peru, Colombia and Brazil.<br />
In <strong>part</strong>icular, FMD serotypes O, A, and C are known to occur in the affected regions. The general FMD<br />
situation in South America significantly improved during the 1990s, due both to regional initiatives 95 and<br />
efforts made by individual countries (Figure 12).<br />
Since 2000, however, a number of countries have <strong>report</strong>ed new and significant outbreaks including<br />
Argentina, Brazil, Paraguay and Uruguay. The evolution of FMD outbreaks in Argentina during 1990-<br />
2005 closely mirrors the general trend in South America as depicted in Figure 11. This situation has<br />
resulted in major trading setbacks for the region.<br />
A significant <strong>part</strong> of Central and South America are currently recognised as FMD-free without or with<br />
vaccination, but some of the countries that are not recognised have significant export potential, including<br />
Argentina and Brazil for which only certain zones are recognised FMD-free 96 . The impact of FMD,<br />
<strong>part</strong>icularly in Brazil and Argentina, has global implications since these are major world exporters of<br />
meat. In the case of Argentina, when the first outbreak occurred in 2000, the country had only recently<br />
gained recognition from the OIE as being FMD-free without vaccination 97 .<br />
The OIE currently recognises two exporting zones in Argentina with respect to FMD status. The zone<br />
situated south of the 42° parallel (South Patagonia) is recognised as “FMD-free without vaccination”,<br />
while the zone situated north of the 42° parallel is recognised as “FMD-free with vaccination” 98 . The<br />
95 Since 1987, an Hemispheric Plan for the Eradication of FMD (PHEFA) has been put in place by the countries of<br />
South America. Clinical cases of FMD decreased considerably throughout the continent: during the early 1990s<br />
national laboratories diagnosed an average of 766 cases per year in South America, but by the late 1990s the<br />
continent-wide average had fallen to 130. In 1999, clinical signs of FMD were absent in 60% of all cattle on the<br />
continent (which represented 41% of all South American herds and covered 60% of the continent’s geographical<br />
area) (A160).<br />
96 According to data from PANAFTOSA/PAHO-WHO, OIE FMD zoning in South America covered as at the end of<br />
2005 78% of the total cattle population (which represented 60% of all South American herds and covered 53% of the<br />
continent’s geographical area). [PANAFTOSA: Pan American FMD Centre]<br />
97 In May 1997, Argentina achieved the classification of FMD free with vaccination, in accordance with Chapter<br />
2.1.1 of the OIE Code. In May 2000, the status of FMD free without vaccination was achieved.<br />
98 For the various implications of vaccination see section 4.2.1.4.<br />
Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 96